Evidence in follow-up and prognosis of esophagogastric junction cancer

Abstract

Five-year survival of tumors of the esophagogastric junction is 50%, in the most favourable stages and with the most effective adjuvant treatments. More than 40% of patients will have recurrences within a short period, usually the first year after potentially curative surgery. Survival after this recurrence is usually less than 6 months because treatment is not very effective, be it palliative chemotherapy, radiotherapy or surgical excision of single recurrences. As the detection of asymptomatic recurrences allows for earlier and more effective treatments to be used, the type and frequency of follow-up has an influence on survival.

Keywords: Adenocarcinoma esofágico; Adenocarcinoma gástrico; Esophageal adenocarcinoma; Esophagogastric junction; Gastric adenocarcinoma; Recurrence; Recurrencia; Supervivencia; Survival; Unión esofagogástrica.